Literature DB >> 12751037

Rotavirus nonstructural protein NSP4 induces heterotypic antibody responses during natural infection in children.

Pratima Ray1, Jyoti Malik, Ravi K Singh, Shinjini Bhatnagar, Rajiv Bahl, Ramesh Kumar, Maharaj K Bhan.   

Abstract

Seroconversion of immunoglobulin A (IgA) and immunoglobulin G (IgG) (> or =4-fold rise) to rotavirus nonstructural protein 4 (NSP4) was determined, by use of enzyme-linked immunosorbent assay with fusion proteins glutathione S-transferase (GST)-NSP4 from strains SA11 (A), 116E (B), and RRV (C), in 40 children with acute rotavirus gastroenteritis and in 30 with the same disease due to other pathogens. The IgG seroconversion rates in the rotavirus group were 67.5%, 70%, and 60% when recombinant (r) NSP4A, -B, and -C, respectively, were used as antigen in the assay, and, for rotavirus-uninfected children, rates were 10%, 13%, and 7%. IgA seroconversion occurred in 57%, 70%, and 50%, respectively, of children with rotavirus gastroenteritis; in rotavirus-uninfected children, 1 child each seroconverted to the different rNSP4s. Among 9 children infected with strain NSP4A, 7, 6, and 5 children showed IgG seroconversion, and, among 18 infected with NSP4A, -B, and -C, 16, 17, and 15, respectively, showed IgG seroconversion. Between NSP4A-infected and NSP4B-infected children, IgA responses were similar to IgG responses. In conclusion, significant NSP4-specific antibody response occurs in natural rotavirus infection, and the antibody response appears to be broad and heterotypic in nature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12751037     DOI: 10.1086/375243

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Genetic characterization of VP3 gene of group A rotaviruses.

Authors:  Swati Subodh; Maharaj K Bhan; Pratima Ray
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

2.  Higher Expression Level and Lower Toxicity of Genetically Spliced Rotavirus NSP4 in Comparison to the Full-Length Protein in E. coli.

Authors:  Mehdi Sahmani; Siavash Azari; Majid Tebianian; Nematollah Gheibi; Farzaneh Pourasgari
Journal:  Iran J Biotechnol       Date:  2016-06       Impact factor: 1.671

3.  Evaluation of serum antibody responses against the rotavirus nonstructural protein NSP4 in children after rhesus rotavirus tetravalent vaccination or natural infection.

Authors:  Esmeralda Vizzi; Eva Calviño; Rosabel González; Irene Pérez-Schael; Max Ciarlet; Gagandeep Kang; Mary K Estes; Ferdinando Liprandi; Juan E Ludert
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

4.  The rotavirus enterotoxin NSP4 directly interacts with the caveolar structural protein caveolin-1.

Authors:  Rebecca D Parr; Stephen M Storey; Deanne M Mitchell; Avery L McIntosh; Minglong Zhou; Kiran D Mir; Judith M Ball
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 5.  Combined use of lactic-acid-producing bacteria as probiotics and rotavirus vaccine candidates expressing virus-specific proteins.

Authors:  Atefeh Afchangi; Tayebeh Latifi; Somayeh Jalilvand; Sayed Mahdi Marashi; Zabihollah Shoja
Journal:  Arch Virol       Date:  2021-02-03       Impact factor: 2.574

6.  Resistance to rotavirus infection in adult volunteers challenged with a virulent G1P1A[8] virus correlated with serum immunoglobulin G antibodies to homotypic viral proteins 7 and 4.

Authors:  Lijuan Yuan; Shinjiro Honma; Inyoung Kim; Albert Z Kapikian; Yasutaka Hoshino
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

7.  Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children.

Authors:  Carl D Kirkwood; Karen Boniface; Simone Richardson; Zenobia F Taraporewala; John T Patton; Ruth F Bishop
Journal:  J Med Virol       Date:  2008-06       Impact factor: 2.327

Review 8.  Rotavirus vaccines and pathogenesis: 2008.

Authors:  Joseph M Hyser; Mary K Estes
Journal:  Curr Opin Gastroenterol       Date:  2009-01       Impact factor: 3.287

9.  Chikungunya infection in India: results of a prospective hospital based multi-centric study.

Authors:  Pratima Ray; Vinod H Ratagiri; Sushil K Kabra; Rakesh Lodha; Sumit Sharma; B S Sharma; Mani Kalaivani; Naveet Wig
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

10.  Oral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in Mice.

Authors:  Hao Feng; Xin Li; Weibin Song; Mei Duan; Hong Chen; Tao Wang; Jiangli Dong
Journal:  Front Plant Sci       Date:  2017-05-31       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.